Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 41Melanoma 9Uterine Cervical Neoplasms 8Endometrial Neoplasms 7Mouth Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Vulvar Neoplasms 2Uterine Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphatic Metastasis 2Leukemia, Lymphocytic, Chronic, B-Cell 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms, Male 2Waldenstrom Macroglobulinemia 1Rhabdomyosarcoma 1Recurrence 1Recurent Vulvar Carcinoma 1Prostatic Neoplasms 1Penile Neoplasms 1Pediatric Patients With Solid Tumors 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Node-positive Breast Cancer 1Neoplasms 1Neoplasm Micrometastasis 1

Interventions

Doxorubicin 20Vincristine 17Zidovudine 13Cyclophosphamide 12Bleomycin 12Etoposide 10Rituximab 6Prednisone 6Interferon alpha-2 6Cytarabine 6Liposomes 5Filgrastim 5Dexamethasone 5tecogalan 4sargramostim 4Specimen Handling 4Methotrexate 4Magnetic Resonance Spectroscopy 4Leucovorin 4Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4Fluorouracil 4Biopsy 4Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Nivolumab 3interferon alfa-n1 2fludarabine phosphate 2fludarabine 2cabozantinib 2Whole-Body Irradiation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × HIV Infections × Sentinel Lymph Node Biopsy × Clear all
NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡